Eisai Co., Ltd. and FRONTEO, Inc. have launched the tumbling and falling prediction system Coroban to medical institutio...
AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the appointme...
Noven Pharmaceutical has announced its decision to appoint Dr. Naruhito Higo as Chief Executive Officer effective O...
Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. have announced the manufacturing and marketing approval in Japan for th...
Japanese firm Takeda Pharmaceutical Company Limited and Denmark based H. Lundbeck A/S jointly announced that the M...
Astellas Pharma Inc. and FibroGen, Inc. have announced that Japan's Ministry of Health, Labour and Welfare (MH...
Kao Corporation has been selected for inclusion in the 2019 Dow Jones Sustainability World Index (DJSI World) and Dow Jo...
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...
Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...
Japan headquartered Toyobo Co., Ltd. has productized a ribonucleic acid (RNA) analysis kit based on a novel system title...
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Company Limited have announced that they have concluded a licens...
Seattle Genetics, Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has...
Japanese firm Astellas Pharma and iota Biosciences, Inc. have announced a joint research and development agree...
Japan headquartered Eisai Co., Ltd. and US based Biogen Inc. have announced the decision to discontinue the Phase III cl...
Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US ...
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...
Daiichi Sankyo Company Limited has announced it has launched a new generic formulation of oxycodone hydrochloride hydrat...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...
